Home Applications 219208 Application 219208
Type NDA
Sponsor NOVARTIS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 VANRAFIA ATRASENTAN HYDROCHLORIDE TABLET;ORAL EQ 0.75MG BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N219208-001 VANRAFIA ATRASENTAN HYDROCHLORIDE EQ 0.75MG BASE TABLET / ORAL RLD, RS 2025-04-02
Orange Book patents# Current patent rows page 1 of 1 · 10 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N219208-001 8623819 2028-08-22 U-3980 2025-04-29 N219208-001 11874283 2032-02-18 U-3980 2025-04-29 N219208-001 10016393 2034-07-07 Drug product 2025-04-29 N219208-001 9364458 2034-07-07 U-3980 Drug product 2025-04-29 N219208-001 11491137 2040-12-16 U-3980 2025-04-29 N219208-001 11998526 2040-12-16 U-3980 2025-04-29 N219208-001 12121509 2040-12-16 U-3980 2025-04-29 N219208-001 12370174 2040-12-16 U-3980 2025-08-21 N219208-001 12521369 2041-03-02 U-3980 2026-02-06 N219208-001 12582631 2043-03-25 U-3980 2026-04-07
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N219208-001 NCE 2030-04-02
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219208-001 VANRAFIA EQ 0.75MG BASE TABLET / ORAL RLD, RS 2025-04-02 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219208-001 VANRAFIA EQ 0.75MG BASE TABLET / ORAL RLD, RS 2025-04-02 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N219208-001 VANRAFIA EQ 0.75MG BASE TABLET / ORAL RLD, RS 2025-04-02 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219208-001 VANRAFIA EQ 0.75MG BASE TABLET / ORAL RLD, RS 2025-04-02 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219208-001 8623819 2028-08-22 U-3980 2025-04-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219208-001 11874283 2032-02-18 U-3980 2025-04-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219208-001 10016393 2034-07-07 Drug product 2025-04-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219208-001 9364458 2034-07-07 U-3980 Drug product 2025-04-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219208-001 11491137 2040-12-16 U-3980 2025-04-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219208-001 11998526 2040-12-16 U-3980 2025-04-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219208-001 12121509 2040-12-16 U-3980 2025-04-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219208-001 12370174 2040-12-16 U-3980 2025-08-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219208-001 12521369 2041-02-23 U-3980 2026-02-06 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219208-001 8623819 2028-08-22 U-3980 2025-04-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219208-001 11874283 2032-02-18 U-3980 2025-04-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219208-001 10016393 2034-07-07 Drug product 2025-04-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219208-001 9364458 2034-07-07 U-3980 Drug product 2025-04-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219208-001 11491137 2040-12-16 U-3980 2025-04-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219208-001 11998526 2040-12-16 U-3980 2025-04-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219208-001 12121509 2040-12-16 U-3980 2025-04-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219208-001 12370174 2040-12-16 U-3980 2025-08-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N219208-001 8623819 2028-08-22 U-3980 2025-04-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219208-001 11874283 2032-02-18 U-3980 2025-04-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219208-001 10016393 2034-07-07 Drug product 2025-04-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219208-001 9364458 2034-07-07 U-3980 Drug product 2025-04-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219208-001 11491137 2040-12-16 U-3980 2025-04-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219208-001 11998526 2040-12-16 U-3980 2025-04-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219208-001 12121509 2040-12-16 U-3980 2025-04-29 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219208-001 8623819 2028-08-22 U-3980 2025-04-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219208-001 11874283 2032-02-18 U-3980 2025-04-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219208-001 10016393 2034-07-07 Drug product 2025-04-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219208-001 9364458 2034-07-07 U-3980 Drug product 2025-04-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219208-001 11491137 2040-12-16 U-3980 2025-04-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219208-001 11998526 2040-12-16 U-3980 2025-04-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219208-001 12121509 2040-12-16 U-3980 2025-04-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219208-001 12370174 2040-12-16 U-3980 2025-08-21 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219208-001 12521369 2041-03-02 U-3980 2026-02-06 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219208-001 12582631 2043-03-25 U-3980 2026-04-07 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219208-001 NCE 2030-04-02 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219208-001 NCE 2030-04-02 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N219208-001 NCE 2030-04-02 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219208-001 NCE 2030-04-02 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join VANRAFIA ATRASENTAN Novartis Pharmaceuticals Corporation 9a7e7f85-bfd0-44a0-beda-3bcfa8215c64 2026-06-12 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 219208 application number: NDA219208
Documents# Document, Submission type, Date table Document Submission type Date 83864 SUPPL 2025-10-21 83863 SUPPL 2025-10-21 81875 ORIG 2025-10-21 81814 ORIG 2025-10-21 82199 ORIG 2025-05-19